Seite - 49 - in Advances in Neuroimmunology

BrainSci. 2016,6, 18 36. Liu,H.; Jacobs,B.S.;Liu, J.;Prayson,R.A.;Estes,M.L.;Barnett,G.H.;Barna,B.P. Interleukin-13sensitivity andreceptorphenotypesofhumanglial cell lines:Non-neoplasticgliaandlow-gradeastrocytomadiffer frommalignantglioma.Cancer Immunol. Immunother. 2000,49, 319–324. [CrossRef] [PubMed] 37. Debinski,W.;Gibo,D.M.;Hulet,S.W.;Connor, J.R.;Gillespie,G.Y.Receptor for interleukin13 isamarker andtherapeutic target forhumanhigh-gradegliomas.Clin. CancerRes. 1999,5, 985–990. [PubMed] 38. Sengupta, S.; Thaci, B.; Crawford,A.C.; Sampath, P. Interleukin-13 receptorα 2-targeted glioblastoma immunotherapy.Biomed.Res. Int. 2014,2014, 952128. [CrossRef] [PubMed] 39. Haque, S.J.; Wu, Q.; Kammer, W.; Friedrich, K.; Smith, J.M.; Kerr, I.M.; Stark, G.R.; Williams, B.R. Receptor-associatedconstitutiveprotein tyrosinephosphataseactivitycontrols thekinase functionof JAK1. Proc.Natl. Acad. Sci.USA1997,94, 8563–8568. [CrossRef] [PubMed] 40. Johnson,L.N.;Noble,M.E.;Owen,D.J.Activeandinactiveproteinkinases: Structuralbasis for regulation. Cell1996,85, 149–158. [CrossRef] 41. Hou, J.; Schindler, U.; Henzel, W.J.; Ho, T.C.; Brasseur, M.; McKnight, S.L. An interleukin-4-induced transcriptionfactor: IL-4Stat.Science1994,265, 1701–1706. [CrossRef] [PubMed] 42. Mikita,T.;Campbell,D.;Wu,P.;Williamson,K.;Schindler,U.Requirements for interleukin-4-inducedgene expressionandfunctionalcharacterizationofStat6.Mol. Cell. Biol. 1996,16, 5811–5820. [CrossRef] [PubMed] 43. Schindler, U.; Wu, P.; Rothe,M.; Brasseur,M.; McKnight, S.L. Components of a Stat recognition code: Evidence for twolayersofmolecularselectivity. Immunity1995,2, 689–697. [CrossRef] 44. Bhattacharjee,A.;Shukla,M.;Yakubenko,V.P.;Mulya,A.;Kundu,S.;Cathcart,M.K. IL-4andIL-13employ discretesignalingpathwaysfor targetgeneexpression inalternativelyactivatedmonocytes/macrophages. FreeRadic. Biol.Med. 2013,54, 1–16. [CrossRef] [PubMed] 45. Darnell, J.E., Jr.;Kerr, I.M.;Stark,G.R. Jak-STATpathwaysandtranscriptionalactivation inresponse to IFNs andotherextracellularsignalingproteins.Science1994,264, 1415–1421. [CrossRef] [PubMed] 46. Mandal,D.;Fu,P.;Levine,A.D.REDOXregulationof IL-13signaling in intestinalepithelial cells:Usageof alternatepathwaysmediatesdistinctgeneexpressionpatterns.Cell. Signal. 2010,22, 1485–1494. [CrossRef] [PubMed] 47. Bluthe,R.M.;Bristow,A.;Lestage, J.; Imbs,C.;Dantzer,R.Central injectionof interleukin-13potentiates LPS-inducedsicknessbehavior inrats.Neuroreport2001,12, 3979–3983. [CrossRef] [PubMed] 48. Shin,W.H.;Lee,D.Y.;Park,K.W.;Kim,S.U.;Yang,M.S.; Joe,E.H.; Jin,B.K.Microgliaexpressinginterleukin-13 undergocelldeathandcontribute toneuronal survival invivo.Glia2004,46, 142–152. [CrossRef] [PubMed] 49. Yang,M.-S.; Ji,K.-A.; Jeon,S.-B.; Jin,B.-K.;Kim,S.U.; Jou,N.; Joe,E.Interleukin-13enhancescyclooxygenase-2 expression inactivatedratbrainmicroglia: Implications fordeathofactivatedmicroglia. J. Immunol. 2006, 177, 1323–1329. [CrossRef] [PubMed] 50. Yang,M.S.; Park, E.J.; Sohn, S.; Kwon,H.J.; Shin,W.H.; Pyo,H.K.; Jin, B.; Choi, K.S.; Jou, I.; Joe, E.H. Interleukin-13and-4 inducedeathofactivatedmicroglia.Glia2002,38, 273–280. [CrossRef] [PubMed] 51. Yasuda, Y.; Shimoda, T.; Uno, K.; Tateishi,N.; Furuya, S.; Yagi, K.; Suzuki, K.; Fujita, S. The effects of MPTPontheactivationofmicroglia/astrocytesandcytokine/chemokine levels indifferentmicestrains. J.Neuroimmunol. 2008,204, 43–51. [CrossRef] [PubMed] 52. Yu, J.T.;Lee,C.H.;Yoo,K.Y.;Choi, J.H.;Li,H.;Park,O.K.;Yan,B.;Hwang, I.K.;Kwon,Y.G.;Kim,Y.M.; et al. Maintenanceofanti-inflammatorycytokinesandreductionofglialactivation in the ischemichippocampal CA1regionpreconditionedwith lipopolysaccharide. J.Neurol. Sci. 2010,296, 69–78. [CrossRef] [PubMed] 53. Zhao,X.;Wang,H.;Sun,G.;Zhang, J.;Edwards,N.J.;Aronowski, J.Neuronal interleukin-4asamodulator ofmicroglialpathwaysandischemicbraindamage. J.Neurosci. 2015,35, 11281–11291. [CrossRef] [PubMed] 54. Latta, C.H.; Sudduth, T.L.;Weekman, E.M.; Brothers,H.M.; Abner, E.L.; Popa,G.J.;Mendenhall,M.D.; Gonzalez-Oregon,F.;Braun,K.;Wilcock,D.M.Determiningtheroleof IL-4 inducedneuroinflammation in microglialactivityandamyloid-βusingBV2microglial cellsandAPP/PS1transgenicmice. J.Neuroinflamm. 2015,12, 41. [CrossRef] [PubMed] 55. Xiong,X.; Xu,L.;Wei, L.;White,R.E.;Ouyang,Y.B.; Giffard,R.G. IL-4 is required for sexdifferences in vulnerability to focal ischemia inmice.Stroke2015,46, 2271–2276. [CrossRef] [PubMed] 56. Lee,H.J.;Park,H.J.; Starkweather,A.;An,K.;Shim, I.Decreasedinterleukin-4release fromtheneuronsof theLocusCoeruleus inresponse to immobilizationstress.Med. Inflamm. 2016,2016, 3501905. [CrossRef] [PubMed] 57. Conti,B.TheScrippsResearchInstitute,CA,USA.Unpublishedwork,2016. 49